
Anthos Therapeutics
Clinical-stage biopharmaceutical company dedicated to developing innovative therapeutic options for the treatment of cardiovascular metabolic diseases.
Employees
Enterprise value
$1.0—1.5b
Authorizing premium user...
Clinical-stage biopharmaceutical company dedicated to developing innovative therapeutic options for the treatment of cardiovascular metabolic diseases.